CHAPTER 1. Industry Overview of Nuclear Medicine
1.1. Definition and Scope
1.1.1. Definition of Nuclear Medicine
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Nuclear Medicine Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Nuclear Medicine Market By Product Type
1.2.3. Nuclear Medicine Market By Application
1.2.4. Nuclear Medicine Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Nuclear Medicine Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Nuclear Medicine Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Nuclear Medicine Market By Product Type
4.1. Introduction
4.2. Nuclear Medicine Revenue By Product Type
4.2.1. Nuclear Medicine Revenue (US$ Mn) and Forecast, By Product Type, 2016-2027
4.2.2. Diagnostic products
4.2.2.1. Diagnostic products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.2. SPECT
4.2.2.2.1. TC-99m
4.2.2.2.2. TL-201
4.2.2.2.3. GA-67
4.2.2.2.4. I-123
4.2.2.2.5. Other SPECT products
4.2.2.3. PET
4.2.2.3.1. F-18
4.2.2.3.2. SR-82/RB-82
4.2.2.3.3. Other PET products
4.2.3. Therapeutic Products
4.2.3.1. Therapeutic Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.2. Alpha Emitters
4.2.3.2.1. RA-223
4.2.3.2.2. Other alpha emitters
4.2.3.3. Beta Emitters
4.2.3.3.1. I-131
4.2.3.3.2. Y-90
4.2.3.3.3. SM-153
4.2.3.3.4. Re-186
4.2.3.3.5. Lu-117
4.2.3.3.6. Other beta emitters
4.2.3.4. Brachytherapy
4.2.3.4.1. Cesium-131
4.2.3.4.2. Iodine-125
4.2.3.4.3. Palladium-103
4.2.3.4.4. Iridium-192
4.2.3.4.5. Other brachytherapy products
CHAPTER 5. Nuclear Medicine Market Revenue By Application
5.1. Introduction
5.2. Nuclear Medicine Revenue (US$ Mn) By Application
5.2.1. Nuclear Medicine Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
5.2.2. Cardiology
5.2.2.1. Cardiology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Neurology
5.2.3.1. Neurology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Oncology
5.2.4.1. Oncology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Thyroid
5.2.5.1. Thyroid Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Lymphoma
5.2.6.1. Lymphoma Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Bone Metastasis
5.2.7.1. Bone Metastasis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Endocrine Tumor
5.2.8.1. Endocrine Tumor Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.9. Others
5.2.9.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. North America Nuclear Medicine Market By Country
6.1. North America Nuclear Medicine Overview
6.2. U.S.
6.2.1. U.S. Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
6.2.2. U.S. Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
6.3. Canada
6.3.1. Canada Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
6.3.2. Canada Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
6.4. North America PEST Analysis
CHAPTER 7. Europe Nuclear Medicine Market By Country
7.1. Europe Nuclear Medicine Market Overview
7.2. U.K.
7.2.1. U.K. Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.2.2. U.K. Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3. Germany
7.3.1. Germany Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.3.2. Germany Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.4. France
7.4.1. France Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.4.2. France Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.5. Spain
7.5.1. Spain Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.5.2. Spain Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.6. Rest of Europe
7.6.1. Rest of Europe Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.6.2. Rest of Europe Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Nuclear Medicine Market By Country
8.1. Asia Pacific Nuclear Medicine Market Overview
8.2. China
8.2.1. China Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.2.2. China Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.3. Japan
8.3.1. Japan Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.3.2. Japan Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.4. India
8.4.1. India Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.4.2. India Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.5. Australia
8.5.1. Australia Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.5.2. Australia Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.6. South Korea
8.6.1. South Korea Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.6.2. South Korea Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.7.2. Rest of Asia-Pacific Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Nuclear Medicine Market By Country
9.1. Latin America Nuclear Medicine Market Overview
9.2. Brazil
9.2.1. Brazil Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.2.2. Brazil Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3. Mexico
9.3.1. Mexico Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.3.2. Mexico Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4. Rest of Latin America
9.4.1. Rest of Latin America Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Nuclear Medicine Market By Country
10.1. Middle East & Africa Nuclear Medicine Market Overview
10.2. Saudi Arabia
10.2.1. Saudi Arabia Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.2.2. Saudi Arabia Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. UAE
10.3.1. UAE Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.3.2. UAE Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.4.2. Rest of Middle East & Africa Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. PLAYER ANALYSIS OF NUCLEAR MEDICINE
11.1. Nuclear Medicine Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Nuclear Medicine Market
CHAPTER 12. COMPANY PROFILE
12.1. Cardinal Health
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (US$ Mn), 2019
12.1.3.2. Cardinal Health 2019 Nuclear Medicine Business Regional Distribution
12.1.4. Product/ Service and Specification
12.1.5. Manufacturing Plant Footprint Analysis
12.2. GE Healthcare
12.3. Curium
12.4. Lantheus Medical Imaging
12.5. Bayer AG
12.6. Bracco Imaging
12.7. Eczacibasi-Monrol Nuclear Products
12.8. Nordion
12.9. Advanced Accelerator Applications
12.10. Others
The global nuclear medicine market in 2027 is expected to be above US$ 12.8 Bn.
The CAGR of the global nuclear medicine market from 2020-2027 is above 9.8%.
Rapid increase in number of patients suffering from chronic cancer, manufacturers approach towards development of patient specific medications, and high investment by major players for R&D activities are major factors expected to drive the growth of global nuclear medicine market.
In product type the diagnostic products segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging, Bayer AG, Bracco Imaging, and Eczacibasi-Monrol Nuclear Products.
The North America is expected to account for major revenue share in the global market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date